Diagnostic Challenges, Prognostic Assessment, and Treatment Strategies in High-Grade Differentiated Thyroid Carcinoma
Endocrinology and Metabolism · 2025
DOI: 10.3803/enm.2025.2725 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, 2025. Verfasst von Chan Kwon Jung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and ICT, Commercialization Promotion Agency for Research and Development Outcomes.
Abstract (Originalsprache)
High-grade differentiated thyroid carcinoma (HGDTC) is a recently codified entity in the 2022 World Health Organization Classification of Endocrine Tumors, defined by a mitotic count of ≥5 mitoses per 2 mm² and/or tumor necrosis in a carcinoma that retains papillary, follicular, or oncocytic differentiation without anaplastic morphology. Although uncommon, HGDTC presents significant diagnostic and therapeutic challenges. This review summarizes current evidence regarding histopathologic recognition, molecular features, prognostic determinants, and evolving treatment paradigms. Particular attention is given to pattern-specific pitfalls such as high-grade papillary thyroid carcinoma, the diffuse sclerosing subtype, and the prognostic influence of the invasion phenotype (encapsulated versus infiltrative). Subcentimeter papillary carcinomas exhibiting increased mitotic activity alone should not be overinterpreted as HGDTC. An integrated, stepwise approach is proposed to enhance diagnostic reproducibility, refine risk stratification, and optimize multidisciplinary management in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Anatomical Pathology, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Förderung
- Ministry of Science and ICT
- Commercialization Promotion Agency for Research and Development Outcomes
Zitieren
APA
Jung, C. K., & Harahap, A. S. (2025). Diagnostic Challenges, Prognostic Assessment, and Treatment Strategies in High-Grade Differentiated Thyroid Carcinoma. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2025.2725
Vancouver
Jung CK, Harahap AS. Diagnostic Challenges, Prognostic Assessment, and Treatment Strategies in High-Grade Differentiated Thyroid Carcinoma. Endocrinology and Metabolism. 2025. doi:10.3803/enm.2025.2725
BibTeX
@article{Jung2025,
author = {Jung, Chan Kwon and Harahap, Agnes Stephanie},
title = {Diagnostic Challenges, Prognostic Assessment, and Treatment Strategies in High-Grade Differentiated Thyroid Carcinoma},
journal = {Endocrinology and Metabolism},
year = {2025},
doi = {10.3803/enm.2025.2725}
}
EUVIMED